Team adds to Oval Medical seed fund
Medical technology firm Team Consulting has joined the consortium of investors that is providing seed funding to Oval Medical Technologies, a developer of medical pre-filled syringes and autoinjectors.
Ickleton, Cambridge-based Team will join others - including Cambridge Angels and Cambridge Capital Group - to provide Oval Medical with close to £500,000 of new funds in exchange for equity.
This investment is expected to enable Oval Medical to advance the development of its injection technology, including the production of new drug containers and prototype injection devices for validation by pharmaceutical partners.
Jerry Turner, Team Consulting’s chief executive officer, will join the board of Oval Medical along with other investment representatives.
Turner said: ‘With many new biological and injectable drugs in development and an associated rising demand for autoinjector technology, device manufacturers face many new challenges. Oval Medical is developing exciting approaches to meeting these.’
Founded in 2009 by Matthew Young, the company’s chief executive officer, Oval Medical develops and maintains its own intellectual property relating to novel pre-filled syringe and autoinjector technology.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
UK Enters ‘Golden Age of Nuclear’
The delay (nearly 8 years) in getting approval for the Rolls-Royce SMR is most worrying. Signifies a torpid and expensive system that is quite onerous...